NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Dec 12, 2014
Insider Transaction Report
Form 4
LARSON BRENT L
VP Finance and CFO
Transactions
- Exercise/Conversion
Common Stock
2014-12-10$0.39/sh+50,000$19,500→ 369,184 total - Tax Payment
Common Stock
2014-12-10$1.31/sh−26,947$35,301→ 342,237 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-12-10+50,000→ 0 totalExercise: $0.39Exp: 2014-12-10→ Common Stock (50,000 underlying)
Holdings
- 95,097(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Shares withheld by the issuer in payment of the option exercise price and to satisfy tax withholding obligations.
- [F2]Option vested 1/3 of the underlying shares annually beginning on 12/10/2005.